Drug-induced liver toxicity /
Saved in:
| Imprint: | New York, NY : Humana Press : Springer, [2018] |
|---|---|
| Description: | 1 online resource (xx, 667 pages) : illustrations (some color) |
| Language: | English |
| Series: | Methods in pharmacology and toxicology, 1557-2153 Methods in pharmacology and toxicology, |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11550444 |
Table of Contents:
- Overview of mechanisms of drug-induced liver injury (DILI) and key challenges in DILI research / Nabil Noureddin and Neil Kaplowitz
- Detection, elimination, mitigation, and prediction of drug-induced liver injury in drug discovery / Francois Pognan
- Drug-induced liver injury (DILI) classification and its application on human DILI risk prediction / Shraddha Thakkar, Minjun Chen, Huixiao Hong, Zhichao Liu, Hong Fang, and Weida Tong
- Physicochemical properties and structural alerts / Lilia Fisk, Nigel Greene, and Russ Naven
- Quantitative structure-activity relationship models for predicting risk of drug-induced liver injury in humans / Huixiao Hong, Jieqiang Zhu, Minjun Chen, Ping Gong, Chaoyang Zhang, and Weida Tong
- Introduction to DILIsym® software, a mechanistic mathematical representation of drug-induced liver injury / Christina Battista, Brett A. Howell, Scott Q. Siler, and Paul B. Watkins
- Prediction of human liver toxicity using in vitro assays : limitations and opportunities / Franck A. Atienzar and Jean-Marie Nicolas
- Use of liver-derived cell lines for the study of drug-induced liver injury / Zhen Ren, Si Chen, Baitang Ning, and Lei Guo
- Evaluation of drug-induced liver injuries (DILI) with human hepatocytes : scientific rationale and experimental approaches / Albert P. Li
- Status and use of induced pluripotent stem cells (iPSCs) in toxicity testing / Min Wei Wong, Chris S. Pridgeon, Constanze Schlott, B. Kevin Park, and Christopher E.P. Goldring
- Engineered human liver cocultures for investigating drug-induced liver injury / Chase P. Monckton and Salman R. Khetani
- Status and future of 3D cell culture in toxicity testing / Monicah A. Otieno, Jinping Gan, and William Proctor
- Reactive metabolite assessment in drug discovery and development in support of safe drug design / Axel Pähler
- In vitro assessment of mitochondrial toxicity to predict drug-induced liver injury / Mathieu Porceddu, Nelly Buron, Pierre Rustin, Bernard Fromenty, and Annie Borgne-Sanchez
- Bile salt export pump : drug-induced liver injury and assessment approaches / Ruitang Deng
- High content screening for prediction of human drug-induced liver injury / Mikael Persson
- Interpretation, integration, and implementation of in vitro assay data : the predictive toxicity challenge / Deborah S. Light, Michael D. Aleo, and J. Gerry Kenna
- Perspectives on the regulatory and clinical science of drug-induced liver injury (DILI) / Mark I. Avigan and Monica A. Muñoz
- Regulatory toxicological studies : identifying drug-induced liver injury using nonclinical studies / Imran Khan and Elizabeth Hausner
- Hy's law and eDISH for clinical studies / John Senior and Ted Guo
- Variability in baseline liver test values in clinical trials : challenges in enhancing drug-induced liver injury assessment in subjects with liver disease / Bereket Tesfaldet, Gyorgy Csako, Tejas Patel, Md Shamsuzzaman, and Eileen Navarro Almario
- Postmarketing surveillance of drug-induced liver injury / S. Christopher Jones, Cindy Kortepeter, and Allen D. Brinker
- Host risk modifiers in idiosyncratic drug-induced liver injury (DILI) and its interplay with drug properties / Camilla Stephens, M. Isabel Lucena, and Raúl J. Andrade
- Human leukocyte antigen (HLA) and other genetic risk factors in drug-induced liver injury (DILI) / Ann K. Daly Immune mechanisms in drug-induced liver injury / Hartmut Jaeschke and Dean J. Naisbitt
- Translational and mechanistic biomarkers of drug-induced liver injury
- candidates and qualification strategies / Daniel J. Antoine
- Causality assessment methods in drug-induced liver injury / Rolf Teschke and Gaby Danan
- Circulating microRNAs as novel biomarkers of drug-induced liver injury in humans / Julian Krauskopf, Jos C. Kleinjans, and Theo M. de Kok
- Systems microscopy approaches in unraveling and predicting drug-induced liver injury (DILI) / Marije Niemeijer, Steven Hiemstra, Steven Wink, Wouter den Hollander, Bas ter Braak, and Bob van de Water
- Noninvasive preclinical and clinical imaging of liver transporter function relevant to drug-induced liver injury / J. Gerry Kenna, John C. Waterton, Andreas Baudy, Aleksandra Galetin, Catherine D.G. Hines, Paul Hockings, Manishkumar Patel, Daniel Scotcher, Steven Sourbron, Sabina Ziemian, and Gunnar Schuetz.